26 results
Thumbnail

D1.428 - Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation

Thumbnail

D1.431 - Associations of the composition of intestinal microbiota with the initial manifestations of IgE-mediated food allergy in children 6-12 months old

Thumbnail

D1.433 - The effect of preventive administration of probiotic strain E. coli 083:H24:K31 on selected immune characteristics of eight-year-old children

Thumbnail

- D3.03 - Trend analysis of the occurrence of allergic diseases in Polish children over the past 30 years

Thumbnail

- D3.05 - Predictive Value of Bronchodilator Reversibility and FeNO in Assessing Positive Outcomes of Bronchial Provocation Tests in Asthma Patients

Thumbnail

- D3.02 - Benefits of non-invasive methods in the diagnosis of occupational asthma: example of asthma due to ammonium persulphate in a hairdresser

Thumbnail

- D3.07 - Allergic Asthma in Children: The Hidden Role of Cockroaches

Thumbnail

- D3.08 - Cross-disciplinary working in adult food allergy: experience from the UK

Thumbnail

- D3.10 - Systemic characteristic of 15-LOX and 5-LOX oxo-metabolites in older patients with aspirin exacerbated respiratory disease

Thumbnail

- D3.11 - Bird-Egg Syndrome and Beyond: Exploring Allergies to Egg Yolk and Seeds from Bird Feed Components

Thumbnail

- D3.12 - A case of Pneumothorax as first manifestation of asthma

Thumbnail

- D3.13 - Real-life experience with tezepelumab in severe allergic asthma

Thumbnail

- D3.14 - Validation of an environmental exposure chamber for the diagnosis of olive tree pollen allergy

Thumbnail

- D3.15 - Mislabeling of Anaphylaxis in the Emergency Department: A Retrospective Study at King Abdulaziz University Hospital, Jeddah

Thumbnail

D3.16 - Recommendations to travelers with pollen allergy, main pollens identified in aerobiological stations from Perú and Spain

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis